The commercial litigation market across the Netherlands and the broader Benelux region has shifted fundamentally over the past decade. Corporate claimants are increasingly uncomfortable paying traditional hourly rates for long-term disputes where the outcome remains uncertain.
Instead, clients now expect their law firms to share the financial risk of the proceedings. Risk-based and deferred fee structures have become the baseline expectation for claimant-side commercial disputes, including shareholder actions, competition damages claims, and high-value breach of contract matters.
For law firms, embracing this change creates a severe working-capital problem that is easy to understate. A major commercial claim before the Dutch courts or an international arbitration tribunal regularly runs for three to five years before reaching a final resolution.
During this multi-year timeline, a firm carrying the case on a contingency or deferred arrangement is entirely self-funding the litigation. The firm must absorb the costs of lawyer time, expert witness fees, and disbursements, all while carrying the overhead of a dedicated team that is generating zero current fee income.
Managing this strain for a single case is feasible. However, for a firm running multiple risk-based matters simultaneously, the cumulative cash-flow demand heavily impacts partner drawings and restricts the firm's capacity to accept new work.
The law firms experiencing the most consistent growth in this competitive environment are those utilizing external litigation funding to manage their working capital. This funding typically operates through two distinct structures.
The first is case-level funding, where a funder directly covers the costs and deferred fees of a specific matter in exchange for a share of the eventual recovery. The firm's immediate financial exposure is relieved on that specific dispute.
The second is portfolio funding, where capital is committed across a broader group of cases under a single agreement. Because returns are calculated at the portfolio level, losses on an individual case are safely absorbed by successes elsewhere, eliminating the binary risk exposure of a case-by-case basis.
Beyond solving the immediate cash-flow burden, external funding fundamentally changes the commercial conversations that firms can have with prospective clients. Historically, law firms routinely declined strong cases from clients who refused hourly billing because the financial risk did not align with the firm's balance sheet.
Introducing a litigation funder shifts that exposure away from the firm entirely. The firm can offer the alternative fee structures clients demand, deferring its fees without triggering the working-capital drag that would otherwise make the instruction commercially unviable.
The direct result for the firms that embrace this model is a vastly expanded addressable market. It also provides a powerful tool for winning competitive pitches where the fee structure itself is part of the selection criteria.
To successfully build these funded relationships, law firms must understand exactly what funders look for during due diligence. Because funders rely heavily on the instructed counsel, they thoroughly vet the firm's track record, the experience of the leading lawyers, and the overarching procedural strategy.
Crucially, funders look for an objective, clear-eyed assessment of the case. Firms that present a claim without acknowledging its vulnerabilities fail to build confidence, whereas transparency regarding both the strengths and risks of a matter fosters a collaborative dynamic that accelerates approval.
For any commercial litigation practice looking to adapt, the path forward begins with a clear internal inventory. Firms need to look at their current pipeline to calculate the total deferred capital demand they face over the next twelve to twenty-four months.
Pinpointing those numbers, alongside identifying the strong cases previously turned down due to cost exposure, highlights exactly where external litigation funding can make the most immediate commercial difference.
← Insights